583 related articles for article (PubMed ID: 16966876)
1. Effective dose scaling factors for use with uranium series cascade impactor data: a reassessment using the IMBA code.
Kim KP; Wu CY; Birky BK; Bolch WE
Health Phys; 2006 Oct; 91(4):331-7. PubMed ID: 16966876
[TBL] [Abstract][Full Text] [Related]
2. Effective dose scaling factors for use with cascade impactor sampling data in tenorm inhalation exposures.
Kim KP; Wu CY; Birky BK; Bolch WE
Health Phys; 2005 Oct; 89(4):359-74. PubMed ID: 16155458
[TBL] [Abstract][Full Text] [Related]
3. Influence of particle size distribution on inhalation doses to workers in the Florida phosphate industry.
Kim KP; Wu CY; Birky BK; Bolch WE
Health Phys; 2006 Jul; 91(1):58-67. PubMed ID: 16775481
[TBL] [Abstract][Full Text] [Related]
4. Internal dose assessment of natural uranium from drinking water based on biokinetic modeling and individual bioassay monitoring: a study of a Finnish family.
Li WB; Salonen L; Muikku M; Wahl W; Höllriegl V; Oeh U; Roth P; Rahola T
Health Phys; 2006 Jun; 90(6):533-43. PubMed ID: 16691101
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of total effective dose due to certain environmentally placed naturally occurring radioactive materials using a procedural adaptation of RESRAD code.
Beauvais ZS; Thompson KH; Kearfott KJ
Health Phys; 2009 Jul; 97(1):50-67. PubMed ID: 19509509
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of Capstone depleted uranium aerosols II: particle size distributions as a function of time.
Cheng YS; Kenoyer JL; Guilmette RA; Parkhurst MA
Health Phys; 2009 Mar; 96(3):266-75. PubMed ID: 19204485
[TBL] [Abstract][Full Text] [Related]
7. Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN.
Kravchik T; Oved S; Paztal-Levy O; Pelled O; Gonen R; German U; Tshuva A
Radiat Prot Dosimetry; 2008; 131(4):418-24. PubMed ID: 18676447
[TBL] [Abstract][Full Text] [Related]
8. Comparison of observed body retention of uranium in natural condition in an average Indian adult with the values predicted by the ICRP biokinetic model.
Singh IS; Jaiswal DD; Nair S; Vijayagopal P; Bhati S; Garg SP
Radiat Prot Dosimetry; 2008; 131(4):425-30. PubMed ID: 18801754
[TBL] [Abstract][Full Text] [Related]
9. Calculation of indoor effective dose factors in ORNL phantoms series due to natural radioactivity in building materials.
Krstic D; Nikezic D
Health Phys; 2009 Oct; 97(4):299-302. PubMed ID: 19741358
[TBL] [Abstract][Full Text] [Related]
10. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
11. Radiation doses and risks from internal emitters.
Harrison J; Day P
J Radiol Prot; 2008 Jun; 28(2):137-59. PubMed ID: 18495991
[TBL] [Abstract][Full Text] [Related]
12. Dose assessment for inhalation intakes in complex, energetic environments: experience from the US Capstone study.
Guilmette RA; Parkhurst MA
Radiat Prot Dosimetry; 2007; 127(1-4):516-20. PubMed ID: 17766261
[TBL] [Abstract][Full Text] [Related]
13. The computation of ICRP dose coefficients for intakes of radionuclides with PLEIADES: biokinetic aspects.
Fell TP
Radiat Prot Dosimetry; 2007; 127(1-4):220-2. PubMed ID: 17921508
[TBL] [Abstract][Full Text] [Related]
14. Inhalation and ingestion intakes with associated dose estimates for level II and level III personnel using Capstone study data.
Szrom F; Falo GA; Lodde GM; Parkhurst MA; Daxon EG
Health Phys; 2009 Mar; 96(3):363-79. PubMed ID: 19204492
[TBL] [Abstract][Full Text] [Related]
15. Uncertainty analysis of doses from inhalation of depleted uranium.
Puncher M; Bailey MR; Harrison JD
Health Phys; 2008 Sep; 95(3):300-9. PubMed ID: 18695411
[TBL] [Abstract][Full Text] [Related]
16. Aerosol sampling system for collection of Capstone depleted uranium particles in a high-energy environment.
Holmes TD; Guilmette RA; Cheng YS; Parkhurst MA; Hoover MD
Health Phys; 2009 Mar; 96(3):221-37. PubMed ID: 19204482
[TBL] [Abstract][Full Text] [Related]
17. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: regional tissue doses for 239PuO2 and 238UO2/238U3O8.
Farfán EB; Huston TE; Bolch WE; Vernetson WG; Bolch WE
Health Phys; 2003 Apr; 84(4):436-50. PubMed ID: 12705442
[TBL] [Abstract][Full Text] [Related]
18. The ICRP protection quantities, equivalent and effective dose: their basis and application.
Harrison JD; Streffer C
Radiat Prot Dosimetry; 2007; 127(1-4):12-8. PubMed ID: 18003712
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
Li WB; Oeh U; Paretzke HG
Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
[TBL] [Abstract][Full Text] [Related]
20. Methods used to calculate doses resulting from inhalation of Capstone depleted uranium aerosols.
Miller G; Cheng YS; Traub RJ; Little TT; Guilmette RA
Health Phys; 2009 Mar; 96(3):306-27. PubMed ID: 19204488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
